SavedAdd your journal

Journals / Clinical and Experimental Health Sciences / 2022 / Cilt: 12 - Sayı: 3

Which Phenotypic Method Is the Most Accurate for Detection of Extended – Spectrum β-Lactamases (ESBLs) in Escherichia coli ?

Montaser M.y. AMRO
Emrah GÜLER
Kaya SÜER
Meryem GÜVENİR
Pages
624–628
Publication Date
2022-09-28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to statistical analysis: There were statistical differences between DDST-CDT (p=

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of the study is to determine the Extended-Spectrum β-Lactamases (ESBLs) by three different phenotypic methods of the Escherichia coli (E. coli) strains that isolated from various clinical samples.
📊
Key Findings & Data:Methods: A total of 93 E. coli samples were isolated from hospitalized patients.
💡
Conclusion & Impact:According to statistical analysis: There were statistical differences between DDST-CDT (p=
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Escherichia coli · ESBL · Enterobacteriaceae

Abstract

Objective: The aim of the study is to determine the Extended-Spectrum β-Lactamases (ESBLs) by three different phenotypic methods of the Escherichia coli (E. coli) strains that isolated from various clinical samples. Methods: A total of 93 E. coli samples were isolated from hospitalized patients. Antibiotic susceptibility tests were done by automated system Phoenix 100 (Becton Dickinson, Sparks, MD, USA). ESBL production was tested by double disc synergy test (DDST), combined disc test (CDT) and three-dimensional test (TDT). All statistical analyses were done using statistical packages SPSS Demo Ver 22 (SPSS Inc. Chicago, IL, USA). Results: In the investigation of ESBL production among E. coli species, 87 (93.5%) strains were ESBL positive by DDST, 73 (78.5%) strains were ESBL positive by CDT, 71 (76.3%) strains were ESBL positive by TDT. According to statistical analysis: There were statistical differences between DDST-CDT (p=

🔖

Cite This Article

AMRO, M. M., GÜLER, E., SÜER, K., GÜVENİR, M. (2022). Which Phenotypic Method Is the Most Accurate for Detection of Extended – Spectrum β-Lactamases (ESBLs) in Escherichia coli ?. Clinical and Experimental Health Sciences, Cilt: 12 - Sayı: 3, 624–628. https://ajindex.com/articles/481071

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Vila J., Sâez-Lôpez, E., Johnson Jr., Römling U., Dobrint U., Cantôn R., Giske Cg., Naas T., Carattoli A., Martinez-Medina M., Bosch J., Retamar P., Rodrîguez-Bano J., Baquero, F., Soto Sm. Escherichia coli: an old friend with new tidings. FEMS Microbiology Reviews 2016; 40(4):437. Abraham E. P., Chain E. An enzyme from bacteria able to destroy penicillin. Nature 1940; 146(3713):837–837. Paterson D. L., & Bonomo R. A. Extended-spectrum β-lactamases: A clinical update. Clinical Microbiology Reviews 2005; 18(4): 657–686.
  2. Etebu E., Arikekpar I. Antibiotics: Classification and mechanisms of action with emphasis on moleculer perspectives. Int. J. Appl. Microbiol. Biotechnol. Res. 2016; 90-101.
  3. Founou R.C., Founou L.L., Essack S.Y. Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis. PLoS ONE 2017, 12, e0189621. New Report Calls for Urgent Action to Avert Antimicrobial Resistance Crisis. Available online: https://www.who.int/news-room/detail/29-04-2019-new-report-calls-for-urgentaction-to-avertantimicrobial
  4. Moland ES, Hanson ND, Black JA, Hossain A, Song W, Thomson KS. Prevalence of newer beta-lactamases in Gram-negative clinical isolates collected in the United States from 2001 to 2002. J Clin Microbiol 2006; 44: 3318–3324.
  5. Drieux L, Brossier F, Sougakoff W, Jarlier V. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect 2008; 14 (suppl 1): 90– 103 Livermore DM. Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother 2001; 47 (3):247-250
  6. Özsoy MF, Öncül O, Yıldırım A, Pahsa A. Genişlemiş spektrumlu beta-laktamazlar: klinik önemi ve getirdiği sorunlar. Flora 2001; 6(Ek1): 3-23. http://eucast.org. Accession date: 14.03.2022
  7. Livermore, DM. Beta-Lactamases in laboratory and clinical resistance. Clinical Microbiology Reviews 1995; 8(4):557–584.
  8. Paterson DL, Bonomo RA. Extended-spectrum betalactamases: a clinical update. Clin Microbiol Rev 2005; 18:657- 86. Henshke-Bar-Meir R., Yinnon A. M., Rudensky B., Attias D., Schlesinger Y., & Raveh, D. Assessment of the clinical significance of production of extended-spectrum βlactamases (ESBL) by Enterobacteriaceae. Infection 2006; 34(2): 66–74
  9. Polsfuss S, Bloembeerg GV, Giger J, Meyer V, Böttger EC, Hombach M. Evaluation of a diagnostic flow chart for detection and confirmation of extended spectrum β-lactamasess (ESBL) in Enterobacteriaceae. Clin Microbiol Infect